The Peril and Promise of Integrons: Beyond Antibiotic Resistance.


Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
06 2020
Historique:
received: 21 08 2019
revised: 13 11 2019
accepted: 09 12 2019
pubmed: 18 1 2020
medline: 26 5 2021
entrez: 18 1 2020
Statut: ppublish

Résumé

Integrons are bacterial genetic elements that can capture, rearrange, and express mobile gene cassettes. They are best known for their role in disseminating antibiotic-resistance genes among pathogens. Their ability to rapidly spread resistance phenotypes makes it important to consider what other integron-mediated traits might impact human health in the future, such as increased virulence, pathogenicity, or resistance to novel antimicrobial strategies. Exploring the functional diversity of cassettes and understanding their de novo creation will allow better pre-emptive management of bacterial growth, while also facilitating development of technologies that could harness integron activity. If we can control integrons and cassette formation, we could use integrons as a platform for enzyme discovery and to construct novel biochemical pathways, with applications in bioremediation or biosynthesis of industrial and therapeutic molecules. Integron activity thus holds both peril and promise for humans.

Identifiants

pubmed: 31948729
pii: S0966-842X(19)30317-8
doi: 10.1016/j.tim.2019.12.002
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-464

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Timothy M Ghaly (TM)

Department of Biological Sciences, Macquarie University, Sydney, NSW 2109, Australia. Electronic address: timothy.ghaly@mq.edu.au.

Jemma L Geoghegan (JL)

Department of Biological Sciences, Macquarie University, Sydney, NSW 2109, Australia.

Sasha G Tetu (SG)

Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia; ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, NSW 2109, Australia.

Michael R Gillings (MR)

Department of Biological Sciences, Macquarie University, Sydney, NSW 2109, Australia; ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, NSW 2109, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH